Cargando…

Procalcitonin in liver transplant patients – yet another stone turned

Liver transplantation has been reported to initiate increases in procalcitonin levels, in the absence of bacterial infection. The results of a study investigating the course of procalcitonin levels over several days after liver transplantation in noninfected patients were recently reported in Critic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Jens-Ulrik, Lundgren, Jens D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374640/
https://www.ncbi.nlm.nih.gov/pubmed/18254924
http://dx.doi.org/10.1186/cc6221
_version_ 1782154501352849408
author Jensen, Jens-Ulrik
Lundgren, Jens D
author_facet Jensen, Jens-Ulrik
Lundgren, Jens D
author_sort Jensen, Jens-Ulrik
collection PubMed
description Liver transplantation has been reported to initiate increases in procalcitonin levels, in the absence of bacterial infection. The results of a study investigating the course of procalcitonin levels over several days after liver transplantation in noninfected patients were recently reported in Critical Care. This study shows that procalcitonin levels increase only transiently, immediately after surgery, and thereafter they rapidly decrease. This new information gives us hope that procalcitonin can be used as a marker of bacterial infection in these patients. Further studies of patients undergoing liver transplantation with and without bacterial infection are needed.
format Text
id pubmed-2374640
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23746402008-05-09 Procalcitonin in liver transplant patients – yet another stone turned Jensen, Jens-Ulrik Lundgren, Jens D Crit Care Commentary Liver transplantation has been reported to initiate increases in procalcitonin levels, in the absence of bacterial infection. The results of a study investigating the course of procalcitonin levels over several days after liver transplantation in noninfected patients were recently reported in Critical Care. This study shows that procalcitonin levels increase only transiently, immediately after surgery, and thereafter they rapidly decrease. This new information gives us hope that procalcitonin can be used as a marker of bacterial infection in these patients. Further studies of patients undergoing liver transplantation with and without bacterial infection are needed. BioMed Central 2008 2008-01-22 /pmc/articles/PMC2374640/ /pubmed/18254924 http://dx.doi.org/10.1186/cc6221 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Commentary
Jensen, Jens-Ulrik
Lundgren, Jens D
Procalcitonin in liver transplant patients – yet another stone turned
title Procalcitonin in liver transplant patients – yet another stone turned
title_full Procalcitonin in liver transplant patients – yet another stone turned
title_fullStr Procalcitonin in liver transplant patients – yet another stone turned
title_full_unstemmed Procalcitonin in liver transplant patients – yet another stone turned
title_short Procalcitonin in liver transplant patients – yet another stone turned
title_sort procalcitonin in liver transplant patients – yet another stone turned
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374640/
https://www.ncbi.nlm.nih.gov/pubmed/18254924
http://dx.doi.org/10.1186/cc6221
work_keys_str_mv AT jensenjensulrik procalcitonininlivertransplantpatientsyetanotherstoneturned
AT lundgrenjensd procalcitonininlivertransplantpatientsyetanotherstoneturned